<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3047110/" ref="ordinalpos=2005&amp;ncbi_uid=2875168&amp;link_uid=PMC3047110" image-link="/pmc/articles/PMC3047110/figure/F6/" class="imagepopup">Figure 6.  From: ERG oncogene modulates prostaglandin <span class="highlight" style="background-color:">signaling</span> in prostate cancer cells. </a></div><br /><div class="p4l_captionBody">Proposed model for ERG functions in prostaglandin signaling pathway. Inhibition of HPGD as result of TMPRSS2-ERG overexpression prevents PGE2 catabolism, thus accumulation of PGE2 will result in uPA activation and cell growth, contributing to the progression of CaP. ERG directly binds to the promoter of uPA.</div></div>